CHM 5.56% 1.7¢ chimeric therapeutics limited

cant stay away, page-3

  1. 296 Posts.
    CHM’s big chance to cause problems was in MMX getting funding for the infrastructure tender and submitting the RFP.

    That has happened – MMX/OPR has received funding from all the major Australian banks plus some international banks. The tender has been submitted on time – and

    Therefore CHM has failed.

    Fair enough, you could argue that the prospect of a takeover of MMX might give CHM some leverage.

    But firstly, I don’t believe MMX management or shareholders want a takeover in the near future. The full value of the company is still being proved up by drilling etc. so a takeover now would undervalue the company.

    Secondly, Sinosteel is not stupid. If they want MMX they will look at the facts/evidence, see that the CHM case is a dud, and then proceed.
 
watchlist Created with Sketch. Add CHM (ASX) to my watchlist
(20min delay)
Last
1.7¢
Change
-0.001(5.56%)
Mkt cap ! $14.89M
Open High Low Value Volume
1.8¢ 1.8¢ 1.7¢ $43.15K 2.425M

Buyers (Bids)

No. Vol. Price($)
10 2771181 1.7¢
 

Sellers (Offers)

Price($) Vol. No.
1.8¢ 438794 3
View Market Depth
Last trade - 16.10pm 08/07/2024 (20 minute delay) ?
CHM (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.